BBIO- Bridgebio Pharma, Inc.

Across the last three months, Bridgebio Pharma, Inc.'s insiders have reduced their positions by a net 56,980 shares worth roughly $4.6M.

BBIO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Homcy Charles J	919.9K	-	-
CEO	Kumar Neil	497.0K	$34.30M	-
CFO	Trimarchi Thomas	336.5K	$26.88M	-
Other	Apuli Maricel	122.7K	$9.80M	-
Dir	Cook Jennifer E.	120.8K	$10.15M	-

Buys and sells only

10 filings · page 12

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 29, 2021	Saunders Brent L51	Director	Buy	17,600	$14.48	$254,879.68	New	-23.5%	-46.7%
Dec 29, 2021	Valantine Hannah51	Director	Buy	1,764	$14.23	$25,101.72	New	-23.5%	-46.7%
Dec 29, 2021	Momtazee James C	Director	Buy	80,000	$14.50	$1,160,000.00	+942.2%	-23.5%	-46.7%
Dec 28, 2021	Daniels Ronald J	Director	Sell	11,745	$12.80	$150,336.00	-100%	-22.3%	-49.8%
Dec 28, 2021	Valantine Hannah51	Director	Buy	3,433	$12.96	$44,475.94	New	-22.3%	-49.8%
Aug 4, 2021	Scheller Richard H90	See Remarks	Sale+OE	13,777	$53.23	$733,316.65	-23.1%	-3.4%	-81.1%
Feb 17, 2021	Scott Randal W.45	Director	Buy	16,000	$62.50	$1,000,000.00	+320.0%	-13.9%	-87.1%
Feb 17, 2021	Stephenson Brian C	See Remarks	Buy	8,000	$62.50	$500,000.00	+2.7%	-13.9%	-87.1%
Jan 26, 2021	Bridgebio Pharma, Inc.	10% Owner	Buy	14,428,836	$0.00	-	-100.0%	-	-
Dec 28, 2020	Turtle Cameron	See Remarks	Sale+OE	19,500	$69.60	$1,357,184.04	-60.8%	-	-